NDAINJECTIONINJECTABLE
Lifecycle
Pre-Launch
Data completeness
0/8 — Limited
Drug data last refreshed 1w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SELENOMETHIONINE SE-75 is a radioactive diagnostic injectable containing selenium-75, used for imaging and diagnostic purposes in nuclear medicine. The product is an organified selenium compound that localizes to specific tissues for diagnostic visualization. It represents a niche radiopharmaceutical with specialized clinical applications.
Pre-Launch
Pre-launch stage indicates small, specialized team focused on regulatory strategy and market access planning rather than commercial scaling.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Currently zero linked job openings reflect pre-launch stage; career opportunities will emerge post-approval through regulatory, clinical, and specialized medical affairs roles. This niche radiopharmaceutical appeals to professionals with nuclear medicine, diagnostics, or orphan/specialty product expertise.
Regulatory Affairs SpecialistNuclear Medicine Product Manager
Worked on SELENOMETHIONINE SE 75 at PharmaLundensis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.